Human Longevity Inc. (HLI) was established by experts in genetic research who were leaders in the field. The company strives to improve health and longevity with a technology that they call “health intelligence.” This technology is a combination of DNA information, machine learning and expert analysis of the data. The new technology could revolutionize modern medicine to become more data-oriented. The team at the company is comprised of experts in multiple fields, including computer science, medical science and researchers.
Human Longevity Inc. has a unique program that gathers your genetic information to create a plan to improve your chances of preventing diseases in a proactive way. As HLI gathers more genetic and health information about individuals, it is better able to make an impact on the medical field’s understanding of human health.
HLI has the largest database of genomic and phenotypic data. Human Longevity Inc. uses this data with machine learning systems to gain new insights that couldn’t be obtained by traditional means. New scientific insights will lead to new treatments and more ways to diagnose health problems. The net result is longer average human life spans.
Human Longevity Inc. basis their health intelligence on data called phenotype. This is an amalgamation of all the observable characteristics of the client. All of a person’s physical traits are considered in compiling this data set. The genetic information is only a small part of the picture of a person’s physical state. HLI uses a comprehensive set of procedures to gather a wide variety of types of information about a client’s phenotype. The net result is to gain the most health intelligence as possible.
There is a great deal of data within each person that can be extracted and compiled as data. Human Longevity Inc. has tens of thousands of genomes and related phenotype data in its database. With this large amount of data, the company is able to find more correlations and gain insights about disease and health issues. Gene sequencing and expert analysis allow HLI to create highly accurate data. Companies are partnering with HLI for their unique ability to analyze the entire human genome.
Machine learning allows HLI to process vast amounts of data at a far greater speed than in previous years. This technology is making it possible for HLI to develop early detection of health problems, customized treatments and better health outlooks for clients that could also save them on their medical costs in the long run.
HLI believes that the cutting-edge technologies that they are using will accelerate the advancement of health care. Their approach of gathering data and using machine learning analysis is transforming the medical industry from being reactive to proactive, personalized and preventative.
The co-founder of HLI, John Craig Venter, is an American scientist and businessman who gained notoriety for drafting the first complete human genome sequence. He is currently the CEO of J. Craig Venter Institute. HLI is based in San Diego, and it was launched in 2013. In 2017, HLI reached a company valuation of more than $1.6 billion.
